Aptagen, LLC
* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.
Receptor Tyrosine Kinase (RET) Mutant (D4) (ID# 7500)
![](https://www.aptagen.com/wp-content/uploads/88.png)
2'-F-RNA
Receptor Tyrosine Kinase (RET) Mutant
Protein
35 nM (reported value)
Selection buffer: RPMI 1640
37°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
Binds to both PC12/MEN2A and PC12/MEN2B.
5'-rGpfCprGpfCprGprGprGprAprApfUprAprGpfUprApfUprGprGprAprAprGprGprApfUprApfCprGpfUprApfUprApfCpfCprGpfUprGpfCprAprApfUpfCpfCprAprGprGprGpfCprAprApfCprGp-3'
![](/wp-content/uploads/apta-sequence-abbr.png)
50
16281.84
511900
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Cerchia, Laura, et al. "Neutralizing Aptamers from Whole-Cell SELEX Inhibit the RET Receptor Tyrosine Kinase." PLoS Biology, 3 (2004): e123
Have your aptamer oligo synthesized ORDER
We are always looking for ways to improve. Please tell us what you think.